MoneyWorks4Me

Cadila Healthcare informs about press release

09 Aug 2017 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Diltiazem Hydrochloride Extended-Release Capsules USP’.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1736.50
Dr. Reddys Labs. 1239.55
Cipla 1325.00
Lupin 1940.95
Zydus Lifesciences 1116.65
View more..